Second, 1 out of 26 ductal carcinoma in situ (DCIS) cases has hypermethylatoin of HOXA11 meanwhile 118 out of 238 IDC cases show a high level of methylation. This evidence concerns the gene HOXA11 and ductal breast carcinoma in situ.